Publication Name	World Journal of Hepatology
Manuscript ID	21019
Country	United States

Received	2015-06-29 09:23
Peer-Review Started	2015-06-29 16:52
To Make the First Decision	2015-07-28 10:52
Return for Revision	2015-08-03 15:15
Revised	2015-08-16 02:20
Second Decision	2015-11-04 18:05
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-11-17 08:37
Articles in Press	2015-11-17 08:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-19 11:57
Publish the Manuscript Online	2015-11-27 17:14

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Hepatic manifestations of non-steroidal inflammatory bowel disease therapy
Manuscript Source	Invited Manuscript
All Author List	Robert Hirten, Keith Sultan, Ashby Thomas and David E Bernstein
Funding Agency and Grant Number
Corresponding Author	Dr. David E Bernstein, MD, Chief of Division of Hepatology, North Shore University Hospital-Long Island Jewish Medical Center, 300 Community Drive, Manhasset, NY 11030, United States. dbernste@nshs.edu
Key Words	Hepatotoxicity; Adverse drug reactions; Drug induced liver injury; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis
Core Tip	Recently the number of medical therapies for inflammatory bowel disease (IBD) has greatly increased. Each medication has its own mechanism of action and side effect profile. This review article discusses the hepatic side effects of medications used to treat IBD enabling physicians to better recognize and manage these complications.
Publish Date	2015-11-27 17:14
Citation	Hirten R, Sultan K, Thomas A, Bernstein DE. Hepatic mani­festations of non-steroidal inflammatory bowel disease therapy. World J Hepatol 2015; 7(27): 2716-2728
URL	http://www.wjgnet.com/1948-5182/full/v7/i27/2716.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i27.2716

Full Article (PDF)	WJH-7-2716.pdf
Full Article (Word)	WJH-7-2716.doc
Manuscript File	21019-Review.docx
Answering Reviewers	21019-Answering reviewers.pdf
Audio Core Tip	21019-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21019-Conflict-of-interest statement.pdf
Copyright License Agreement	21019-Copyright assignment.pdf
Peer-review Report	21019-Peer-review(s).pdf
Scientific Misconduct Check	21019-Scientific misconduct check.pdf
Scientific Editor Work List	21019-Scientific editor work list.pdf